Study reveals drug interactions that may reduce mortality in
Patient health records revealed two drug combinations that may reduce mortality rates in breast cancer patients, according to a study led by researchers at the Stanford University School of Medicine.

The drugs involved were commonly used noncancer drugs that turned out to be associated with a longer average survival rate in breast cancer patients.

The study was published online Dec. 9 in the Journal of the American Medical Informatics Association. The lead author is Stanford postdoctoral scholar Yen Low, PhD. The senior author is Nigam Shah, MBBS, PhD, associate professor of medicine and of biomedical data science....

http://med.stanford.edu/news/all-news/2016/12/study-reveals-drug-interactions-that-may-reduce-mortality.html
Like
Comment
Share
Dr. B●●v G●●●l
Dr. B●●v G●●●l Test
Good Stuff
Aug 23, 2017Like